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Dependence of norfloxacin diﬀusion across
bilayers on lipid composition†
Sowmya Purushothaman, Jehangir Cama and Ulrich F. Keyser*
Antibiotic resistance is a growing concern in medicine and raises the need to develop and design new
drug molecules that can eﬃciently inhibit bacterial replication. Spurring the passive uptake of the drug
molecules is an obvious solution. However our limited understanding of drug–membrane interactions
due to the presence of an overwhelming variety of lipids constituting cellular membranes and the lack
of facile tools to probe the bio-physical interactions between drugs and lipids imposes a major
challenge towards developing new drug molecules that can enter the cell via passive diffusion. Here, we
used a label-free micro-fluidic platform combined with giant unilamellar lipid vesicles to investigate the
permeability of membranes containing mixtures of DOPE and DOPG in DOPC, leading to a label-free
measurement of passive membrane-permeability of autofluorescent antibiotics. A fluoroquinolone drug,
norfloxacin was used as a case study. Our results indicate that the diffusion of norfloxacin is strongly
dependent on the lipid composition which is not expected from the traditional octanol–lipid partition
co-efficient assay. The anionic lipid, DOPG, slows the diffusion process whereas the diffusion across
liposomes containing DOPE increases with higher DOPE concentration. Our findings emphasise the
need to investigate drug–membrane interactions with focus on the specificity of drugs to lipids for efficient
drug delivery, drug encapsulation and targeted drug-delivery.
Introduction
The development of antibiotics has been instrumental in combating
a large number of infectious diseases over the past century.1
However, with the excessive and at times unnecessary use of
antibiotics, antibacterial resistance is on the rise. The rapid
spread of resistance and simultaneous decline in the discovery
of novel antimicrobials pose a challenge to drug development
and treatment of bacterial infections.
A large number of antibiotics function by targeting critical
intracellular processes after overcoming the cellular membrane
barrier.2 Small molecules and drugs can overcome this barrier
by (i) binding to active transporters to cross the membrane,
(ii) targeting bacteria-specific membrane components involved in
cell-wall synthesis,3 (iii) passive diﬀusion across lipid membranes
or (iv) via liposomal carriers that act as cargos to transport them to
the target cells.4,5 One of the origins of antibiotic resistance is the
reduction of bacterial membrane permeability to drugs. Reduced
uptake in turn reduces drug accumulation within the cell leading
to decreased cell susceptibility. The permeability is reduced
when there are alterations in the target membrane-composition,6,7
mutations in porins present in the outer membrane or when
there is an over-expression of eﬄux pumps that are mainly
present in the inner membrane.4,8
The factors that cause these mutations and adaptations leading
to drug resistance are poorly understood.9 Eﬃcient translocation
of drugs across the membrane is therefore one of the major
challenges in drug development. Designing new drugs with
increased rates of diﬀusion and accumulation faces a further
setback because of the multitude of macromolecules present in
the membrane, many of which are not even identified.10–12
While designing drugs requires an understanding of the
drug–membrane interaction mechanisms, drugs themselves
can potentially influence the activity of various membrane
proteins or enzymes.13,14 Understanding lipid–drug interactions
is also important for developing efficient liposomal drug-delivery
systems. Therapeutically, liposomal drug delivery is one of the
most successful delivery systems owing to its bio-compatibility
and low toxicity.15–18 Despite their wide applicability, there are
limited laboratory-based techniques to probe liposome–drug
bio-compatibility for efficient drug-encapsulation.19–21
There is extensive literature where a variety of elegant
techniques such as NMR,22 X-ray diﬀraction,23 FTIR,22 CD,6,24
fluorescence anisotropy, FRET25 and FPE26 were used to show
that the interaction of drugs with membranes is lipid-composition
specific.27,28 Most of the techniques give valuable information about
drug–lipid interactions at a molecular level. The studies have
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revealed that the charged state, hydrophobicity and the head-
group structure dictate the passage of drugs via membranes.29
However, these techniques can often only elucidate interactions
of drugs with single component lipid systems in contrast to the
multi-component membrane architecture found in nature. The
analysis and interpretation of the data obtained from these
techniques is non-trivial and often cannot be directly used to
extract permeability. The bio-chemical diversity combined with
the lack of technologies to probe into the bio-physical char-
acteristics of lipid–drug complexes make the understanding of
the mechanisms underpinning lipid–drug interactions challenging.
Unlocking the drug–lipid interactions by developing techniques that
can facilitate screening of lipids based on properties such as
the bio-compatibility of lipids to a specific drug molecule, its
permeability, stability and toxicity is therefore crucial for drug
development as well as for the design of optimised drug-delivery
systems.
In addition, while most of these studies involve labelling the
molecules, other more popular techniques such as the partition
co-eﬃcient measurement30 or HPLC31,32 investigate only the
bulk properties based on the octanol–drug interaction33,34 as
opposed to a more relevant lipid–drug interaction. Amphiphilicity
is the key feature for treating octanol as a simple model to
membrane lipids. However, this crude chemical similarity cannot
encompass the complex structural variations found in lipids.
Octanol itself possesses an internal structure leading to the
formation of inversemicellar aggregates (of 18.5–21.5 Å diameters)35
which could lead to the underestimation of partition co-efficients.36
Therefore, the prediction of molecular interactions of drug
molecules with respect to octanol cannot fully reflect the drug–
membrane interactions occurring in biological systems as shown
in this article.
Microfluidic devices are emerging as powerful tools in bio-
sensing and medical diagnostics.37,38 Major advantages of
microfluidic devices are the ease of sample handling, modularity,
portability, potential high-throughput capability and cost eﬀective-
ness, all of which are desirable for bio-sensing and analysis.39,40–42
In recent years the application of theminiaturemicrofluidic devices
has also been extended to drug screening43 and testing targeted
delivery systems for anti-cancer drugs.44 Combining liposomal
membrane systems with microfluidics can therefore provide an
ideal tool to probe the structure–function relationship between
lipid membranes and drugs.
In this work, we built upon the previously described in-house
microfluidic setup45 combined with giant unilamellar vesicles
as model membranes to probe the diﬀusion of norfloxacin across
vesicular lipid membranes with specific compositions inspired by
the E. coli inner membrane composition. Norfloxacin is widely
used in the treatment of infectious conditions such as urinary tract
infections,46 prostate, skin, pulmonary and digestive infections.47–49
It belongs to the fluoroquinolone family of drugs that target
bacterial enzymes involved in DNA replication thereby inhibiting
cell division.50 The exact mechanism of its action, particularly
from its uptake by the membrane through drug–lipid interactions
to drug–DNA complex formation however is not well established.51
The use of a microfluidic platform for the above-mentioned
advantages combined with the liposomes52 of various compositions
provides a facile tool to measure the diffusion across a variety of
lipid compositions.
We investigated the eﬀect of the bilayer forming lipid DOPC
(1,2-dioleoyl-sn-glycero-3-phosphocholine), non-bilayer forming
lipid DOPE (1,2-dioleoyl-sn-glycero-3-phosphoethanolamine) and
charged (anionic at pH 7) lipid DOPG (1,2-dioleoyl-sn-glycero-3-
phospho-(10-rac-glycerol) (sodium salt)) on the permeability of
norfloxacin across bilayers (see Fig. 1 for molecular structures).
The compositions were chosen close to their concentrations found
in the inner membrane of E. coli. Furthermore, to keep the
hydrophobic area constant, DOPE, DOPG and DOPC lipids were
used since all of them contain 18 carbon chains with a cis
unsaturation at the 9th carbon position. It should be noted that
the real membrane, however, contains a mixture of PE or PG
lipids with varying chain lengths or degrees of unsaturation. PE
constitutes about 70% of the total lipids found in the E. coli
membrane whereas PG forms about 23% of the total lipids. Our
approach exploits the auto-fluorescence properties of norfloxacin
thereby enabling a label-free measurement of drug permeation
across the lipid bilayer.45,53 The permeation of norfloxacin is
investigated at two pH conditions, at pH 5 at which most of the
norfloxacin molecules are positively charged and at pH 7 at which
norfloxacin is uncharged/zwitterionic.54
We show that the lipid composition does in fact play a crucial
role in the passive diﬀusion of small molecules such as norfloxacin
(see Fig. 1). In particular, we found that the charged lipid slows
the diﬀusion at pH 7 whereas zwitterionic lipids at the same
concentrations increase the permeability. This is in contrast to
the observations made for ciprofloxacin, another fluoroquinolone
drug, where the drug was found to interact more strongly with
anionic lipids at a similar pH.29,55 Furthermore, we found that the
diﬀusion also depends on the amount of PE present in the
membrane with lower concentrations retarding the diﬀusion. It
is thus clear that changing the lipid composition of a membrane
Fig. 1 Vesicles made from diﬀerent lipid mixtures are exposed to the
fluoroquinolone antibiotic norfloxacin at time t0 at pH 7. By observing
the autofluorescence of norfloxacin we can quantify the permeation of
norfloxacin into lipid vesicles at tf. By using diﬀerent lipid compositions we
can study if permeation is governed by lipid composition. We used three
diﬀerent lipids in varying mixtures and compositions. Chemical structures
of the three lipids and norfloxacin are shown on the right. Please note that
the figure is not drawn to scale.
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has a considerable eﬀect on its permeability to norfloxacin.
These results reinforce the importance of studying drug trans-
port in a lipid based model system in order to better understand
transport properties across cellular membranes.
Materials
DOPG, DOPE, and ITO glass slides were purchased from Sigma.
DOPC was purchased from Avanti Polar Lipids. We used 100 mM
sucrose in 5 mM phosphate buﬀer for pH 7 or 100 mM sucrose
in 5 mM acetic acid buﬀer for pH 5.
Preparation of GUVs
GUVs were prepared using the standard electro-formation
technique. Briefly, lipids were mixed in the desired ratios,
70 : 30 DOPC :DOPE, 30 : 70 DOPC :DOPE, 70 : 30 DOPC :DOPG
and pure DOPC in chloroform to obtain a final concentration of
0.5 mg ml1 lipid mixture. A thin layer of the lipid film was
deposited on ITO glass slides and left to dry for two hours in a
vacuum desiccator. The dried film was rehydrated in the buﬀer
and an AC electric field was applied at 2.6 V peak-to-peak at
10 Hz for 3 hours followed by 4.4 V at 4 Hz for 30 minutes. The
vesicles were stored at 4 1C and were used within 48 hours.
Optical setup
A custom-built UV epi-fluorescence microscope was used to
perform all the experiments.45 The optical setup consists of a
broadband white light source (EQ99FC, Energetiq), whose out-
put is routed through a monochromator (Monoscan 2000,
OceanOptics) to select the desired excitation wavelength
(340 nm). The excitation beam is directed onto the microfluidic
device via a dichroic mirror (DLHS UV 351–355, Qi-Optiq,
Germany) and a 60 water immersion UPLSAPO Olympus
objective (NA 1.2). The emitted light is recorded using an Evolve
512 EMCCD camera (2 ms exposure, bin 2, 65 fps) using
Micromanager 1.4,56 an open source microscopy platform. UV
fused silica lenses were used for light navigation to optimise
transmission in the UV region.
Microfluidic chip design
The microfluidic chip (Fig. 2) was constructed using standard
photo- and soft-lithography techniques.57 Two designs were
used for the experiments (Fig. 2(a) and (b)). For experiments
carried out at pH 7, a small chip containing a B28 mm long
channel folded 4 times was used whereas for experiments
carried out at pH 5, where the diﬀusion was much slower, a
chip with an B380 mm long channel folded 15 times (see
Fig. 2(b)) was used. In both the chips, a series of pillars in the
inlet reservoirs were designed to filter out vesicles of size
greater than 40 mm diameter from entering the channel. The
microfluidic flows were controlled by applying suction at the
outlet reservoir using a neMESYS syringe pump system with a
250 ml Duran borosilicate glass syringe (ILS, Germany). At the
inlets, pipette tips with 40 ml of vesicle stock solution and 40 ml
of 2 mM norfloxacin solution, respectively, were fed into the
two reservoirs. Once the fluorescence intensities were uniform, data
collection was initiated. The flows were reduced from 30 ml h1
down to 3 ml h1 for visualisation and collection of videos.
Data analysis
In order to calculate the permeability coeﬃcient, we deter-
mined the normalised fluorescence intensity diﬀerences
between the exterior and the interior of the vesicles at t = 0 (DI1)
and later at tf (DI2) given by the following equations (see
Fig. 2(c)):
DI1 ¼ Iout  I1
Iout
; ðt ¼ 0Þ (1)
DI2 ¼ Iout  I2
Iout
; t ¼ tfð Þ (2)
where I1 and I2 refer to the average internal fluorescence
intensities measured around the centre of the vesicles at times
t = 0 (or t0) and t = tf. Iout denotes the fluorescence intensity
outside the vesicle. The relative intensities DI1 at t = 0, the
starting point, and DI2, t = tf, at which the vesicle has travelled a
certain distance in the norfloxacin solution, were calculated
(for full details of the theoretical model and MATLAB image
analysis, see ref. 45). The t0 point for the longer chip was along
the length of the channel that ran parallel to the serpentine, see
Fig. 2(b), L1. For the smaller chip, t0 was simply the point
Fig. 2 Experimental setup. (a) Design of the small microfluidic chip used
in the experiments carried out at pH 7. The schematic also depicts the
intensity variations measured across two observation points along the
channel. (b) Design of the chip used for measurements carried out at pH 5.
The chip has a longer channel and hence vesicles could be observed for
longer periods of time of about 60 s or more. (c) Typical vesicles observed
along the channel. Our automated MATLAB routine identifies vesicles
(events) and tracks the vesicles across frames. The routine finds the centre
of the vesicles (pixels), radius (mm) and velocity (mm s1) from the frame
rate and traced centre position information from all frames where the
event was detected (for more details, see ESI†). The data are then further
processed using an automated LABVIEW routine (ESI†) that processes the
data by removing the outliers, fitting and finally calculating the permeability
for each data set.
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immediately after mixing of the drug and the vesicle stream
flows, see Fig. 2(a), L.
A MATLAB routine extracts the list of files and frame
numbers containing vesicles and calculates the radius, velocity,
centre co-ordinates, circularity and the total average intensity
after background subtraction of the detected vesicles. We
developed further post-processing routines to remove the outliers,
fit data and finally calculate the permeability co-eﬃcient thereby
fully automating the routines. A detailed description of the process
can be found in the ESI.†
After solving the diﬀusion model, we obtained the following
equation that was used for analysis:45
P ¼ R
3t
ln DI2  DI1 þ 1ð Þ (3)
where P is the permeability coeﬃcient, R the vesicle radius
and t the time taken to travel from the initial to final vesicle
detection point.
Results
Vesicles containing diﬀerent compositions of DOPE and DOPG
lipids were made as detailed before. The permeability values
calculated using the procedure described in the previous section
were based on the calculation of the increase in intensity inside
the vesicle as the auto-fluorescent norfloxacin permeates the
vesicle from the external solution. At the initial viewpoint,
defined as time t = 0, the vesicles have just been exposed to
norfloxacin and appear dark when viewed at 340 nm excitation
(shown in grey in Fig. 3(a–c)). As the vesicle travels along themicro-
fluidic channel, norfloxacin from the surroundings permeates
through the membrane making the vesicle appear brighter.
The normalised intensity diﬀerence between the outer
region (Iout) and the intensity calculated at the center (I1 at
t = 0 and I2 at t = tf respectively) of the vesicles containing 30 : 70
DOPE :DOPC lipids is shown in Fig. 3(a–c). Here, each data
point represents one individual vesicle measurement. The
initial relative intensity DI1 at t = 0 of the vesicles is shown as
grey points, with a linear fit shown as a black line to facilitate
the visual comparison of the data points at t = 0 (DI1) and
tf (DI2). As the vesicles travel longer distances (Fig. 3(b) and (c))
the difference between Iout and I2 decreases in comparison to
the difference between Iout and I1. The difference in the intensities
between the two observation points is a direct measurement of the
amount of norfloxacin permeating the membrane. A histogram of
the permeability values obtained for all the tracked vesicles is
plotted as shown in Fig. 3(d) and in the subsequent graphs
presented in the article. The bin size is chosen based on the Rice
rule where the number of bins is 2n1/3, n being the number of data
points. For pH 7 measurements, a density distribution function is
fit to the histogram using MATLAB’s ‘histfit’ function by selecting
the lognormal distribution which is given by:
f ðx; m; sÞ ¼ 1
xs
ﬃﬃﬃﬃﬃ
2p
p exp ðln x mÞ
2
2s2
 
; x4 0
where m and s are the log mean and log standard deviations.
The mean is given by exp mþ s
2
2
 
and the variance by
exp(2m + s2)(exp(s2)  1). The histograms with the respective
fits are shown in Fig. 3(e–g). Fig. 3 clearly demonstrates that the
vesicles remain intact for several minutes in the channel and
the permeability of norfloxacin measured at various observation
points gives a consistent value of 0.44  0.03  105 cm s1,
validating the technique.
Fig. 3 Diﬀusion of norfloxacin into vesicles as a function of time at pH 7. Plots show the intensity diﬀerence DI for vesicles made from lipid mixtures
containing 30 mol% DOPE and 70 mol% DOPC travelling along the microfluidic channel for distances L = 0 or t = 0 (a–c, grey points) compared to
DI detected at (a) L = 7.4 mm (tB 10 s), (b) L = 12.58 mm (tB 17 s) and (c) L = 19.5 mm (tB 23 s). For all plots grey points indicate initial DI at t0 while the
blue dots indicate measurements at the respective tf positions. The black line is a fit to the data at L = 0. There is a clear shift in DI as vesicles travel along
the channel indicating norfloxacin permeation through the membrane. (d) Fits to the histograms of the obtained permeabilities (see text). For 30 : 70
DOPE :DOPC we obtain 0.44  0.03  105 cm s1 at all three time points as the average value, as expected. (e–g) Histograms of the permeability at
various length scales with the fits according to the equation as shown (see main text).
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Fig. 4(d–f) presents the data obtained at pH 7 at which
norfloxacin is predominantly uncharged or zwitterionic,54 and
can permeate through the lipid membrane more easily. As a
control, we also performed experiments at pH 5 at which
norfloxacin is in a charged state and hence cannot permeate
through lipid membranes easily. The results are presented in
Fig. 4(a–c) for all the lipid compositions investigated in this
work. The three control measurements show an almost perfect
overlap between the normalised intensity DI1 at t = 0 and the
normalised intensity DI2 calculated after a minute’s exposure to
the drug (Fig. 4(a–c)). This proves that the vesicles are intact
and the transport is negligible as expected for the charged form
of norfloxacin at pH 5. The corresponding histogram fits are
shown in Fig. 4(g). For pH 5 experiments the histogram was
fitted using a ‘Gaussian’ distribution:
f ðx; m; sÞ ¼ 1
s
ﬃﬃﬃﬃﬃ
2p
p e
ðxmÞ2
2s2
The most probable permeability for all three lipids is 0, as
expected for the control measurements.
In contrast, our results at pH 7, shown in Fig. 4(d–f) for pure
DOPC (Fig. 4(d)), 70 :30 DOPE:DOPC (Fig. 4(e)), and 30 :70 DOPG:
DOPC (Fig. 4(f)) show significant changes in DI indicating the
permeation of norfloxacin into vesicles. It is also important to note
here that the final observation point for our pH 7 measurements
was only after 10 s. The diffusion time is thus six times shorter than
the timescale in all control experiments presented in Fig. 4(a–c),
indicating a relatively faster permeation of the drug. As before, we
use log-normal fits to the permeability histograms (Fig. 4(h)).
We observed that the DOPC membrane was the most perme-
able at pH 7 with a value of 0.81  0.01  105 cm s1 followed
by the vesicles containing a mixture of DOPC and DOPE, with high
amounts of DOPE (70%) having a value of 0.68 0.07 105 cm s1.
However at lower concentrations of DOPE (30%), the permeability
dropped to 0.44 0.03 105 cm s1 (see Fig. 6). At lower amounts
of the charged lipid, DOPG (30%), the permeability was found to be
0.43 0.02 105 cm s1. At pH 5, the permeability was not aﬀected
by lipid composition at these timescales (see Fig. 4(a–c and g)).
These data are remarkable as they clearly show that there is a
significant difference in permeability values for different lipid
mixtures. These results cannot be predicted from themeasurements
of the partition coefficient in octanol.
In order to widen the range of lipid mixtures we also compare
results of mixtures of 70 :30 DOPE:DOPC lipids (Fig. 5(a)) and
30 :70 DOPE:DOPC. At the lower DOPE concentration, the perme-
ability of the vesicles was lower by a factor of two (0.44  0.03 
105 cm s1) than the pure DOPC counterparts (0.81  0.01 
105 cm s1). Interestingly, when the concentration of the non-
lamellar lipid was increased, the vesicles became more permeable
(0.68  0.07  105 cm s1) compared to the vesicles with lower
amounts of DOPE (Fig. 5). Therefore, we find that the diﬀusion
of norfloxacin is faster by roughly 30% for vesicles made from
mixtures containing less DOPC in comparison to vesicles con-
taining more DOPC in DOPE. This is interesting, as our original
data suggest that diﬀusion through DOPC is faster. However,
one clearly cannot conclude that the DOPC content determines
permeability.
It is worth mentioning that since DOPC vesicles showed the
fastest increase in intensity inside the vesicle attributed to the
permeation of norfloxacin, all the measurements for DOPE and
DOPG compositions were therefore taken for the same time
scales of approximately 10 s (7.4 mm along the channel).
Fig. 4 Diﬀusion of norfloxacin in buﬀers at pH 5 (a–c) and 7 (d–f) for a distance of 45.5 mm (pH 5) and 7.4 mm and at different lipid compositions (a and
d) 100% DOPC, (b and e) 70 : 30 DOPE :DOPC and (c and f) 30 : 70 DOPG :DOPC. (a–c) Control measurements for all lipid mixtures showing that the
vesicles are impermeable for charged norfloxacin at pH 5 at these time scales. For all lipid mixtures DImeasurements coincide perfectly with the fit (black
line) representing DI(t0) proving negligible diffusion of norfloxacin for up to 60 s. (d and e) In stark contrast, DI shifts to lower values for all three mixtures
at pH 7 when the uncharged norfloxacin is present. Obviously the change in DI is more pronounced in pure DOPC membranes indicating higher
permeability for norfloxacin (d). The data shown here are the results of a single experiment. Additional independent runs were performed for each
composition (see ESI†). (g) Permeability histograms as fitted to the distribution for pH 5. The most probable values are 0 as expected for the control
measurement. (h) Histograms for the data at pH 7 indicating that permeability depends on the lipid mixture.
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The overall results regarding the extracted permeability
values obtained for all lipid compositions in this study are
summarised in Fig. 6.
Discussion
Passive transport of drug molecules across lipid membranes is
a complex process as it depends on the changes in the inter-
molecular forces acting in lipid membranes in response to the
physiological conditions (temperature, pH and pressure) as
well as the chemical properties of drug molecules (solutes).
The complexity increases due to the lack of techniques to probe
intermolecular forces and the bio-chemical mechanisms of
drug–membrane interactions. While a thorough investigation
of these bio-chemical and bio-physical factors is desirable for
drug development and design, our technique nevertheless
provides an alternative for screening drug molecules for various
lipid compositions. Our experiments also validate the label-free
and quasi high-throughput micro-fluidic technique to determine
the permeability co-efficient for norfloxacin across vesicles with a
wide range of lipid compositions. The experiment proves that lipid
composition significantly affects the passive transport of norfloxacin
across the membrane.
The experiments were performed at pH 5 and 7. At pH 5
norfloxacin is positively charged and hence has a very low aﬃnity
for the hydrophobic and non-polar core of the lipid membrane.
Consequently the permeability of norfloxacin at pH 5 across lipid
vesicles is very low and not measureable in the time scales observed
here. We will therefore examine the structural diﬀerences between
lipids that contribute to the variations in permeability of vesicles for
norfloxacin at pH 7. The results of the permeability measurements
with the standard errors from independent experiments (see ESI†
for additional data sets) are combined in Fig. 6. To emphasize the
strong dependence of permeability of norfloxacin on the lipid
composition, we also presented the permeability of norfloxacin into
DPhPC lipid vesicles obtained from our previous measurement.45
The discussion is divided into four parts: (1) the large
disparity between the permeability of DOPC and the previously
used DPhPC lipid vesicles for norfloxacin. (2) The eﬀect of the
presence of low amounts of the non-lamellar lipid DOPE in
DOPC vesicles. This is found to reduce the permeability of the
membrane to norfloxacin. (3) A comparison of assays containing
small amounts of DOPG, an anionic lipid at pH 7 in DOPC and
low amounts of the non-lamellar lipid DOPE in DOPC and
finally (4) higher permeability at high DOPE concentrations.
For the first part, our investigation shows that DOPC is more
permeable to norfloxacin in comparison to the previously measured
value for DPhPC (see Fig. 6). The diﬀerence in the permeability of
the two lipids is more than one order of magnitude which is
surprisingly high for PC membranes with the same head groups.
If we consider the structural diﬀerences between DOPC and DPhPC,
both contain the same head group but diﬀer in their hydrophobic
chain structure (Fig. 1). DPhPC contains 16 carbon chains
with branched methyl groups at each node in contrast to an
18 : 1 carbon chain with a cis-double bond at the 9th carbon
position in the case of DOPC.
We are able to rule out photo-oxidation of the double bonds
in DOPC as a possible cause since the vesicles were intact at pH
Fig. 5 Comparison of permeability of vesicles with low and high amounts of DOPE. (a) At higher DOPE concentrations (70%), the diﬀerence between the
intensities at the start and the final observation point is larger with brighter vesicles at the end tf. This indicates a faster diﬀusion of norfloxacin across the
vesicles. (b) At lower concentrations (30%), the intensity variation is less indicating slower diﬀusion. These observations indicate that composition as well
as concentration of lipids influences the diﬀusion of norfloxacin across membranes. (c) Histogram fits of the permeability values of 70 : 30 DOPE :DOPC
vesicles (0.68  0.07  105 cm s1) and 30 : 70 DOPE :DOPC vesicles (0.44  0.03  105 cm s1).
Fig. 6 Permeability of vesicles containing DOPC, DOPE and DOPG lipids
at various concentrations at pH 7. Pure DOPC is the most permeable. The
eﬀects of small amounts of the non-lamellar lipid DOPE or DOPG are
similar indicating no preference of norfloxacin to a charged moiety. At
higher concentrations of DOPE the permeability goes up significantly
indicating the possible eﬀect of curvature frustration. The errorbars are
within the legend size. The permeability value of DPhPC obtained from the
literature45 is shown for comparison. The permeability of norfloxacin is
clearly dependent on the type of lipid and the relative concentration.
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5 for more than 60 s. Molecular dynamics simulations58,59 and
X-ray diﬀraction experiments indicate that the branched hydro-
carbon chain in the case of DPhPC does not alter the partition
coeﬃcient significantly in comparison to their straight-chain
counterparts.58 Furthermore, the thickness of the bilayer of
DPhPC is similar to that of DOPC (B36 Å).60 These factors
evidently indicate that the most widely used solubility diﬀusion
model which relates the permeability to the thickness of the
membrane cannot be used to explain the process.
A possible explanation could be drawn based on an improved
three-slab model which incorporates area per lipid molecule
to describe the permeability of small molecules across lipid
membranes.61 The branched chain region of DPhPC has bends
at the tetra carbon positions leading to interposed chains. This
reduces the trans–gauche isomerisation and provides structural
stability. Furthermore, molecular dynamics simulations showed
that there were fewer cavities present in the hydrocarbon region
which restricts the mobility of small neutral molecules across
the bilayer.58,59 The area per lipid molecule for DPhPC is much
larger (80 Å2)60 than DOPC (72 Å2)60 considering that DPhPC has
only 16 carbon chains. The three-slab model predicts that the
resistance to the mobility of the solute predominantly comes
from the interfacial region. Since the effective free volume (owing
to its large area) is much smaller for DPhPC, the permeability
values for small neutral molecules such as norfloxacin are smaller
compared to its straight chain counterparts. The experiments and
the simulation conclude that the differences in the permeability of
DPhPC and its straight chain counterparts are predominantly due
to the restricted diffusion arising from the presence of methyl
groups in the hydrocarbon chain region. The methyl groups
therefore increase the diffusion time for molecules across
DPhPC bilayers in comparison to the DOPC bilayers where
there are no branched structures in the chain region. Our
experiments are in line with the simulation58,59 and X-ray
diffraction61 results describing the permeability of small molecules.
We observe that the diffusion of norfloxacin across DPhPC is much
slower than across DOPC bilayers.
Next, we inspect the permeability of vesicles containing
small amounts of DOPE (30%). DOPE has the same chain
configuration as DOPC but has a much smaller headgroup.
The characteristic features of DOPE are its ability to form non-
lamellar structures and the propensity of forming hydrogen
bonds between the amine group present in the headgroup and
water resulting in a small headgroup.62 This acts like a glue and
keeps the lipid molecules closely packed near the headgroup
region. When a small amount of DOPE is added, the diﬀusion
is therefore reduced since norfloxacin cannot access the hydro-
phobic region as easily as it can in the case of DOPC. This could
explain the small permeability coeﬃcient in the case of 30 : 70
mixtures of DOPE :DOPC vesicles. This also indicates that not
only the type of lipid but also the amount of lipids present in a
membrane influences the permeability of norfloxacin or small
molecules across membranes. This re-aﬃrms the complex non-
linear behaviour of drug molecules with lipid membranes.
When we compare the mixtures of DOPE :DOPC (3 : 7) and
DOPG :DOPC (3 : 7) vesicles, the former containing a non-lamellar
lipid and the latter containing an anionic lipid, the eﬀect of
both kinds of lipids on the permeability of bilayers to norfloxacin
seems to be very similar. In the case of the anionic vesicle (DOPC:
DOPG), the electrostatic interaction due to the presence of anionic
headgroups restricts the passage of neutral norfloxacin across the
bilayer. Previous studies have shown that PG lipids have high
propensity of forming interlipid hydrogen bonds. Molecular
dynamics simulations show that about 30% of PG headgroups
are involved in intramolecular hydrogen bonding where the
hydroxyl headgroup donates a hydrogen to a phosphate (and to
some extent the glycero-ester) oxygen atom. Another 45% of PG
molecules are involved in hydrogen bonding with the PC lipid.
The overall eﬀect of this is increasing order or having a more
regular arrangement of lipids thereby making it less permeable
to norfloxacin.63
Interestingly, the experiment indicates that at the same
concentration of either type of lipid, the eﬀect on norfloxacin
permeability is not aﬀected by the composition of the anionic
or non-bilayer lipid. At much higher concentrations of DOPE
(70%) however (Fig. 5 and 6), a higher permeability was
observed (Fig. 6). At 70% DOPE, the lipid membrane is in a
highly stressed state.64 Higher concentration of non-bilayer
lipids increases the drive to form non-lamellar phases. Since
the lipids are bound in a lamellar conformation, the membrane
experiences high curvature elastic stress.65 The interaction of
vesicles with another neutral molecule therefore paves the way
for the molecule into the vesicle relatively quickly compared to
vesicles with low amounts of DOPE.66 However, it is also likely
that the vesicles may contain a range of DOPE concentrations.
The spread in our data is broad indicating that the eﬀect could
be due to both curvature frustration and varied composition.
While this remains a qualitative description, a thorough analysis
of drug–membrane interactions will provide more insight into
their behaviour.
To summarize, the passive permeability of norfloxacin across a
bilayer depends extensively on the type of lipid and relative
abundance in a non-trivial way. Our experiments also indicate
that not only the head group but also the hydrophobic chain
structure aﬀects the permeation of drugs across membranes in a
complex way. The presence of charged DOPG lipid could be one of
the key factors to slow down the transport of norfloxacin across the
bilayer. On the other hand, from a therapeutic viewpoint, these
results indicate that for more eﬃcient drug transport antibiotics
should be tested on diﬀerent lipid mixtures to obtain accurate
results. In future, a comparison of the permeability of the
individual lipid components presented here can be compared
to the permeability values obtained for bilayers formed using
membrane extracts (e.g. E. coli membrane extract) to under-
stand the cumulative role of lipid composition in regulating the
permeation of antibiotics through membranes.
Conclusion
We have shown that microfluidics is a powerful tool to measure
the passive membrane permeability of drugs, in particular,
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norfloxacin across lipidmembranes. The technique was successfully
used to measure permeability coeﬃcients for a statistically
significant number of vesicles for a wide range of lipid compositions
without the need to investigate the structural nuances of lipids and
drugs. The modularity of the technique also demonstrates the
potential to be further extended into multiplexed devices for a full
lipodome analysis for a variety of drugs making the selection of
drug–lipid pairs less time consuming. The information obtained
from the method can aid in the development of more efficient
encapsulation methodologies in liposomes and designing drugs
based on their preference to interact with specific lipid molecules.
The technique is a viable alternative to the established octanol–drug
partition co-efficient technique which cannot account for the
influence of lipid structure. It also has the advantage of being able
to be developed into high throughput screening assay which may
not be provided by other recentmethods.67 Our results demonstrate
that lipid composition as well as constitution greatly affects the
permeation of molecules. In contrast to ciprofloxacin, which is
another fluroquinolone drug, the diffusion of norfloxacin
across membranes is slower in the presence of an anionic lipid
emphasising the fact that drug–membrane interactions are
complex and their understanding is crucial for the development
of drugs. Our technique can be extended to understand the
permeability and kinetics of uptake of a range of fluorescent
small molecules67 or nanoparticles with excitation ranging from
the visible to near ultra-violet region.
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